ArticleOncotarget2016

The reverse-mode NCX1 activity inhibitor KB-R7943 promotes prostate cancer cell death by activating the JNK pathway and blocking autophagic flux.

Zhou Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.